LTTS partners with NVIDIA to deliver digital twin platform for respiratory diagnostics

L&T Technology Services has announced the development of an AI-powered digital twin platform for respiratory diagnostics and lung navigation. With this platform, LTTS aims to deliver scalable, low-latency solutions that enhance diagnostic precision and improve accessibility for healthcare providers worldwide.

The platform will combine LTTS’ expertise in platform engineering, AI-driven diagnostics, connected health systems, and advanced imaging and visualization with NVIDIA AI infrastructure. The solution integrates with CT imaging and leverages deep learning models to create a 3D digital twin of lung anatomy, providing visualization of airways, blood vessels, lung lobes, and lesions. 

It utilises NVIDIA MONAI for medical image segmentation and NVIDIA TensorRT for optimized AI inference to enable interactive visualisation, precise path planning, and navigation support for bronchoscopy.

“AI is reshaping what’s possible in diagnostics and medical technology,” said Alind Saxena, Executive Director and President of Mobility and Tech at L&T Technology Services. “Our collaboration with NVIDIA combines LTTS’ expertise in AI-driven diagnostics and predictive analytics, with NVIDIA’s powerful, modeling and visualization platform. This lets us engineer a digital twin platform that not only enhances diagnostic accuracy but also gives clinicians an immersive, real-time planning tool ultimately helping deliver better outcomes for patients around the world.”

The platform will evolve the snapshots taken into living breathing models that evolve with the patient, delivering intuitive, clinically meaningful simulations that mirror real-world anatomy. This helps transform surgical planning and advancing care for serious conditions such as lung cancer, COPD and infectious diseases.

“Working with LTTS to accelerate the development of AI-enabled medical technology demonstrates how NVIDIA is empowering the healthcare industry with accelerated computing and AI innovation,” said David Niewolny, Director of Business Development for Healthcare/Medical at NVIDIA.